• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

4.290 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.290
Bid (Size) 1.730 (100)
Ask (Size) 4.880 (3,000)
Prev. Close 4.290
Today's Range 4.290 - 4.290
52wk Range 3.760 - 14.73
Shares Outstanding 93,100,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
February 19, 2026
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
February 16, 2026
Management will participate in three upcoming investor healthcare conferences 
From Myriad Genetics, Inc.
Via GlobeNewswire

Performance

YTD
-30.1%
-30.1%
1 Month
-26.9%
-26.9%
3 Month
-44.5%
-44.5%
6 Month
-27.2%
-27.2%
1 Year
-68.9%
-68.9%

More News

Read More
News headline image
3 Cash-Burning Stocks We Keep Off Our Radar
February 05, 2026
Via StockStory
Topics Bankruptcy
News headline image
1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm
February 02, 2026
Via StockStory
News headline image
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
January 27, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
January 21, 2026
Via StockStory
Topics Economy Stocks
News headline image
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
January 12, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
3 Stocks Under $10 We Think Twice About
January 04, 2026
Via StockStory
News headline image
3 Unprofitable Stocks That Fall Short
January 01, 2026
Via StockStory
News headline image
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
December 22, 2025
Via StockStory
News headline image
Why Myriad Genetics (MYGN) Stock Is Up Today
December 09, 2025
Via StockStory
Topics Artificial Intelligence
News headline image
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
December 09, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?
December 08, 2025
Via StockStory
Topics Stocks
News headline image
1 Healthcare Stock with Promising Prospects and 2 We Question
December 02, 2025
Via StockStory
Topics Economy Stocks
News headline image
Why Myriad Genetics (MYGN) Stock Is Trading Lower Today
December 01, 2025
Via StockStory
Topics Government
News headline image
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
November 25, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know
November 24, 2025
Via StockStory
Topics Economy Government
News headline image
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know
November 21, 2025
Via StockStory
Topics Economy
News headline image
Why Myriad Genetics (MYGN) Stock Is Up Today
November 19, 2025
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment
November 18, 2025
Via StockStory
Topics Artificial Intelligence
News headline image
1 High-Flying Stock with Solid Fundamentals and 2 We Question
November 13, 2025
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
November 11, 2025
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
November 11, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
November 10, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.290
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 02/20/26 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 399.40M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 399M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap